MARK CHOQUETTE: Open Payments
NPI 1366623886 · ABBEVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 13 payments from 11 companies in 2025. Trend: 2023 $131 · 2024 $118 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Verona Pharma, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: MOUNJARO, VERQUVO, REXULTI, Auvelity, FANAPT, XHANCE, CAPLYTA, Ohtuvayre.
Industry payments across AL — which companies pay providers there.
